Viewing Study NCT02764593


Ignite Creation Date: 2025-12-25 @ 1:03 AM
Ignite Modification Date: 2026-02-23 @ 4:54 AM
Study NCT ID: NCT02764593
Status: COMPLETED
Last Update Posted: 2022-11-29
First Post: 2016-05-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety Testing of Adding Nivolumab to Chemotherapy in Patients With Intermediate and High-Risk Local-Regionally Advanced Head and Neck Cancer
Sponsor: RTOG Foundation, Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2016-06
Start Date Type: None
Primary Completion Date: 2018-09-25
Primary Completion Date Type: ACTUAL
Completion Date: 2022-02-21
Completion Date Type: ACTUAL
First Submit Date: 2016-05-04
First Submit QC Date: None
Study First Post Date: 2016-05-06
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2022-11-22
Last Update Post Date: 2022-11-29
Last Update Post Date Type: ACTUAL